Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own ...

The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years ...

Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, has said he will step down from the role in the coming months, kicking off the search for a successor. Dolsten’s ...

US pharmaceutical giant Pfizer on Tuesday said its chief scientific officer Mikael Dolsten, a key figure behind the development of the company's Covid-19 vaccine, would step down. Dolsten will be ...

Boshoff replaces Mikael Dolsten, who led research and development at the drug giant for 15 years and who announced his plans to retire in July. The news may disappoint some investors, who may have ...

Pfizer Inc. (PFE) named oncology chief and company veteran Chris Boshoff as its new chief scientific officer on Wednesday, replacing Mikael Dolsten starting Jan. 1. The drug company had been ...

As we announced earlier this year, Dr. Mikael Dolsten, Pfizer's chief scientific officer, will depart from Pfizer after 15 years of leading Pfizer's research efforts. Our progress for selecting a ...

Replaces Mikael Dolsten (Il Sole 24 Ore Radiocor) - New York, 20 Nov - The US pharmaceutical Pfizer said that it has appointing Chris Boshoff as chief scientific officer and president in charge of ...